Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$408,882
+$9,594 QoQ
Shares Held
2,609
-0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#982
of 1,603 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Intrua Financial, LLC holds $17,604,029 across 11 Drug Manufacturers - General names. NVS ranks #9 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
19,859 | $4,997,318 | |
| 2 | LLY |
ELI LILLY & Co
|
2,244 | $2,691,521 | |
| 3 | JNJ |
Johnson & Johnson
|
10,446 | $2,652,970 | |
| 4 | AMGN |
Amgen Inc
|
5,070 | $1,835,948 | |
| 5 | PFE |
Pfizer Inc
|
65,137 | $1,568,498 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,442 | $1,120,248 | |
| 7 | GSK |
GSK plc
|
16,873 | $884,482 | |
| 8 | MRK |
Merck & Co., Inc.
|
6,787 | $872,129 |
All Filings in NVS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $408,882 | 2,609 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $399,288 | 2,614 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $408,922 | 2,966 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $315,598 | 2,461 | Shares | Sole | 2025-10-29 | |
| 2025-03-31 | $209,136 | 1,876 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $220,309 | 2,264 | Shares | Sole | 2025-05-28 | |
| 2024-09-30 | $263,740 | 2,293 | Shares | Sole | 2025-05-28 | |
| 2024-06-30 | $256,036 | 2,405 | Shares | Sole | 2025-05-28 | |
| 2024-03-31 | $233,119 | 2,410 | Shares | Sole | 2025-05-28 | |
| 2023-12-31 | $244,044 | 2,417 | Shares | Sole | 2025-05-28 | |
| 2023-09-30 | $256,381 | 2,517 | Shares | Sole | 2025-05-28 | |
| 2023-06-30 | $253,990 | 2,517 | Shares | Sole | 2025-02-13 | |
| 2023-03-31 | $233,772 | 2,541 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $222,899 | 2,457 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $271,203 | 3,568 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $349,277 | 4,132 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $340,119 | 3,876 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $406,298 | 4,645 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $372,426 | 4,554 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $315,599 | 3,459 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $294,906 | 3,450 | Shares | Sole | 2021-04-30 | |
| No filing history on record for this holder in this stock. | ||||||